文献速递临床试验与 GCP基础与转化研究

无创迷走神经刺激治疗急性缺血性卒中(NOVIS):随机临床试验研究方案

NOn-invasive Vagus nerve stimulation in acute Ischemic Stroke (NOVIS): a study protocol for a randomized clinical trial.
PubMed 文献 · Trials · 2020-10-26

主要终点为第5天MRI评估的最终梗死体积,假设nVNS可改善半暗带恢复并缩小梗死体积,为后续更大规模试验提供依据。

要点

  • 发病12小时内随机,1:1分配至nVNS联合标准治疗或单纯标准治疗。
  • nVNS干预持续5天,主要终点为第5天MRI最终梗死体积。
  • 假设nVNS通过改善半暗带恢复缩小最终梗死体积。

核心结论

  • 假设nVNS联合标准治疗可改善半暗带恢复并缩小最终梗死体积,为更大规模试验提供可行性依据。

研究设计与样本

  • 单中心前瞻性随机临床试验,采用盲法结局评估。
  • 干预组接受5天nVNS联合标准治疗,对照组仅标准治疗。

关键数值与推荐

  • 主要终点为第5天MRI评估的最终梗死体积。
  • 随机化时间窗为临床卒中发作后12小时内。
  • 试验注册号ClinicalTrials.gov NCT04050501,注册日期2019年8月8日。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Secondary damage due to neurochemical and inflammatory changes in the penumbra in the first days after ischemic stroke contributes substantially to poor clinical outcome. In animal models, vagus nerve stimulation (VNS) inhibits these detrimental changes and thereby reduces tissue injury. The aim of this study is to investigate whether non-invasive cervical VNS (nVNS) in addition to the current standard treatment can improve penumbral recovery and limit final infarct volume. METHODS: NOVIS is a single-center prospective randomized clinical trial with blinded outcome assessment. One hundred fifty patients will be randomly allocated (1:1) within 12 h from clinical stroke onset to nVNS for 5 days in addition to standard treatment versus standard treatment alone. The primary endpoint is the final infarct volume on day 5 assessed with MRI. DISCUSSION: We hypothesize that nVNS will result in smaller final infarct volumes as compared to standard treatment due to improved penumbral recovery. The results of this study will be used to assess the viability and approach to power a larger trial to more definitively assess the clinical efficacy of nVNS after stroke. TRIAL REGISTRATION: ClinicalTrials.gov NCT04050501 . Registered on 8 August 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van der Meij A, van Walderveen MAA, Kruyt ND, et al. NOn-invasive Vagus nerve stimulation in acute Ischemic Stroke (NOVIS): a study protocol for a randomized clinical trial. Trials. 2020. PMID: 33106174. doi:10.1186/s13063-020-04794-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。